Advancing global programmatic management of latent tuberculosis infection for at risk populations

Getahun Haileyesus, Matteelli Alberto, Abubakar Ibrahim, Hauer Barbara, Pontali Emanuele, Migliori Giovanni Battista

Source: Eur Respir J 2016; 47:1327-1330
Journal Issue: May
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Getahun Haileyesus, Matteelli Alberto, Abubakar Ibrahim, Hauer Barbara, Pontali Emanuele, Migliori Giovanni Battista. Advancing global programmatic management of latent tuberculosis infection for at risk populations. Eur Respir J 2016; 47:1327-1330

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk of latent tuberculosis infection among healthcare trainees
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012


The risk factors of latent tuberculosis infection among health care workers in South Korea, an intermediate tuberculosis burden country
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018




Incidence of TB latent infection in health care workers in a low TB prevalence country
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015



Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016


The risk of tuberculosis infection in health workers
Source: Eur Respir J 2005; 26: Suppl. 49, 190s
Year: 2005

The global epidemiology of HIV
Source: Eur Respir Monogr 2014; 66: 1-11
Year: 2014


Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Source: Eur Respir J 2010; 36: 1242-1247
Year: 2010



Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Cost-effectiveness of two latent tuberculosis infection screening strategies
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018




Childhood tuberculosis: progress requires an advocacy strategy now
Source: Eur Respir J 2012; 40: 294-297
Year: 2012



High risk of tuberculosis in health care workers in Romania
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006


Monitoring latent tuberculosis infection diagnosis and management in the Netherlands
Source: Eur Respir J 2016; 47:1492-1501
Year: 2016



Peculiarities of children's latent tuberculosis infection diagnostic in condition of ecological, social and economic crisis
Source: Eur Respir J 2002; 20: Suppl. 38, 115s
Year: 2002

Screening for latent tuberculosis in health care workers at low, moderate and high risk for tuberculosis exposure: a cost-effectiveness analysis
Source: Annual Congress 2003 - Control of tuberculosis
Year: 2003


Knowledge and management of tuberculosis among general practitioners in a high burden developing country
Source: Eur Respir J 2006; 28: Suppl. 50, 377s
Year: 2006

A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014



Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015